# NovaBridge Biosciences: Form SCHEDULE 13D/A, filed Aug 7, 2025

- Company: [NovaBridge Biosciences](/companies/nbp.md) (CIK 1778016)
- Form: SCHEDULE 13D/A
- Filed: 2025-08-07
- Accepted by EDGAR: Aug 7, 2025, 16:57 ET
- Period: not reported
- Accession: 0001415889-25-021279
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1778016/000141588925021279/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1778016/000141588925021279/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1778016/000141588925021279/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Aug 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-021279. Last ingested by Listed: Oct 28, 2026, 07:01 ET. No prices; not investment advice.